Demonstrating the Clinical and Economic Value of Pharmaceuticals in a New U.S. Political Administration
PHILADELPHIA, Feb. 9 /PRNewswire/ -- ExL Pharma today announced the start of the first annual conference on Managed Markets Insight & Marketing for the Pharmaceutical Industry at the Loews Philadelphia Hotel. The conference will provide managed markets marketers with strategic insights needed to prepare for future changes in health care, and to be informed regarding potential strategies to consider when developing biopharmaceutical value propositions for payers.
With a new political administration expected to address healthcare policy issues and expand federal government involvement in healthcare, including potentially direct drug price negotiation, the two-day conference will feature industry leaders and other experts on key topics including consumerism, Medicare Part D, and potential implications for managed markets marketing professionals to consider based upon stated policy positions being debated by the 111th Congress and the new Obama presidential administration.
The keynote speaker, Stan Bernard, MD, MBA, president, Bernard Communications, will comment on the future of pharma. Bernard will focus on understanding the implications and applications of U.S. Pharma's transition to a mature industry for managed markets marketing.
Douglas Jordan, senior vice president and managed markets practice leader, Euro RSCG Life, will be discussing insights and strategies to help ensure marketers successfully address the emerging needs of a diverse and evolving healthcare stakeholder group.
Key components of Jordan's presentation include the application of Customer Relationship Marketing (CRM) in the managed markets environment, and development of fully integrated programs that apply innovation and technology to meet the diverse needs and target audiences biopharmaceutical manufacturers seek to engage across all payor channels.
"There are many issues and challenges biopharmaceutical marketers need to consider in today's dynamic marketplace," Jordan said. "More than ever, brand marketers must establish a clear and compelling Value Proposition for payer decision makers that supports brand positioning, and achieves favorable access and reimbursement on public and private payer formularies."
For additional information on the conference or to arrange an interview, contact Carrie Yamond at 212-367-6943 or Carrie.email@example.com.
About ExL Pharma:
ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.
About Euro RSCG Life:
Euro RSCG Life aligns the company's 50 health-focused offices in 30 countries. It creates a single network with over 1,500 employees offering clients comprehensive communications disciplines, including advertising, public relations, event promotion, medical education, digital marketing, direct to patient and consulting services. The network's client roster includes GlaxoSmithKline, Novartis, Pfizer, sanofi-aventis, Schering-Plough and Wyeth. Euro RSCG Life is part of Euro RSCG Worldwide, a leading global marketing communications agency, and the largest unit of Havas, the world's fourth-largest communications group (Euronext Paris SA: HAV.Pa).
CONTACT: Carrie Yamond Euro RSCG Life PR (212) 367-6943 Carrie.firstname.lastname@example.org
|SOURCE Euro RSCG Life|
Copyright©2009 PR Newswire.
All rights reserved